Justin M S Lee1,2, Thomas A Nelson1,2, Richard H Clayton2,3, Nicholas F Kelland1. 1. Department of Cardiology Sheffield Teaching Hospitals NHS Trust Sheffield UK. 2. INSIGNEO Institute of In Silico Medicine University of Sheffield Sheffield UK. 3. Department of Computer Science University of Sheffield Sheffield UK.
Abstract
BACKGROUND: Despite studies using localized high density contact mapping and lower resolution panoramic approaches, the mechanisms that sustain human persistent atrial fibrillation (AF) remain unresolved. Voltage mapping is commonly employed as a surrogate of atrial substrate to guide ablation procedures. OBJECTIVE: To study the distribution and temporal stability of activation during persistent AF using a global non-contact charge density approach and compare the findings with bipolar contact mapping. METHODS: Patients undergoing either redo or de novo ablation for persistent AF underwent charge density and voltage mapping to guide the ablation procedure. Offline analysis was performed to measure the temporal stability of three specific charge density activation (CDA) patterns, and the degree of spatial overlap between CDA patterns and low voltage regions. RESULTS: CDA was observed in patient-specific locations that partially overlapped, comprising local rotational activity (18% of LA), local irregular activity (41% of LA), and focal activity (39% of LA). Local irregular activity had the highest temporal stability. LA voltage was similar in regions with and without CDA. CONCLUSION: In persistent AF, CDA patterns appear unrelated to low voltage areas but occur in varying locations with high temporal stability.
BACKGROUND: Despite studies using localized high density contact mapping and lower resolution panoramic approaches, the mechanisms that sustain human persistent atrial fibrillation (AF) remain unresolved. Voltage mapping is commonly employed as a surrogate of atrial substrate to guide ablation procedures. OBJECTIVE: To study the distribution and temporal stability of activation during persistent AF using a global non-contact charge density approach and compare the findings with bipolar contact mapping. METHODS: Patients undergoing either redo or de novo ablation for persistent AF underwent charge density and voltage mapping to guide the ablation procedure. Offline analysis was performed to measure the temporal stability of three specific charge density activation (CDA) patterns, and the degree of spatial overlap between CDA patterns and low voltage regions. RESULTS: CDA was observed in patient-specific locations that partially overlapped, comprising local rotational activity (18% of LA), local irregular activity (41% of LA), and focal activity (39% of LA). Local irregular activity had the highest temporal stability. LA voltage was similar in regions with and without CDA. CONCLUSION: In persistent AF, CDA patterns appear unrelated to low voltage areas but occur in varying locations with high temporal stability.
Persistent forms of atrial fibrillation (AF) represent more advanced atrial disease than paroxysmal AF.
However, the mechanisms for persistence are still debated and may involve multiple wavelets, endo‐epicardial dissociation, or drivers.
,
,
,
Clinical studies using dominant frequency analysis of roving contact catheter data to locate driver regions have had mixed success.
,
Subsequently, endocardial basket contact mapping catheters were used to demonstrate rotors and showed promising responses to treatment,
but the results of more recent meta‐analyses have been equivocal.
,
Atrial substrate changes detectable during clinical electrophysiology studies include low voltage areas (LVA) or fractionated signals.
Although LVA is advocated as a target for ablation,
,
more recent studies have described marked variation in the extent of LVA observed depending on cycle length and direction of wave front activation, and also in sinus rhythm versus AF.
,
Complex, fractionated signals themselves could represent either active drivers or wavefront collision or fusion and the initial success of targeting complex atrial electrograms reported by Nademanee
was not replicated in the randomized Substrate and Trigger Ablation for Reduction of Atrial Fibrillation (STAR‐AF) II trial.Combined charge density and ultrasound mapping (AcQMap, Acutus Medical) is possible with a novel system employing a spherical catheter with six splines, each of which has eight ultrasound transducers and electrodes. Rapid ultrasound cardiac chamber geometry combined with the ability to collect up to 150 000 non‐contact charge density samples per second allows acquisition of full chamber, high resolution electrical activity.
Several stereotyped charge density activation (CDA) patterns were described during mapping of AF with this system, namely focal activity (FA), local rotational activity (LRA), and local irregular activity (LIA). LRA shows a regionally organized pattern of conduction that rotates in one direction around a confined zone (clockwise or counter‐clockwise) and subtends a path of ≥270°, FA indicates radial wavefronts propagating from a single location, while LIA is a disorganized pattern of conduction with repetitive, multidirectional, isthmus‐like conduction through a confined zone that may enter, exit, and pivot within and around the zone (Figure 1). Initial clinical results using this technology to guide ablation have been reported in a single arm study with 73% freedom from AF at 12 months after a single ablation procedure for persistent AF.
More recently, non‐contact data from the AcQMap system have been validated against standard contact electrograms demonstrating a high degree of correlation for morphology and timing.
FIGURE 1
Example charge density activation patterns
Example charge density activation patternsThe purpose of this study was to describe the spatial distribution and temporal stability of CDA identified using this novel mapping system in a cohort of patients with persistent AF, and to determine if there was any relationship between LVA (using conventional bipolar voltage mapping techniques) and CDA.
METHODS
Following granting of European CE mark and US FDA approval, we obtained local institutional approval to use the novel AcQMap system to treat AF, and all patients in the study gave informed written consent. Between September 2018 and November 2019, sixteen consecutive patients underwent an electrophysiology study and ablation for persistent AF using both AcQMap (Acutus Medical) and Ensite Precision (Abbott Medical) systems.
Electrophysiology study and ablation
All procedures were performed under general anesthetic with transoesophageal echocardiography. Patients were routinely anticoagulated with direct oral anticoagulants (DOAC). Femoral venous access was used for double trans‐septal puncture, followed by heparinization to ACT >350 s. The baseline charge density map (pre‐PVI) was acquired for 30 s during AF with AcQMap, followed by a high density (>3000 points) contact map of the left atrium (LA) during AF using a multipolar catheter, either Advisor FL SE or Advisor HD Grid SE (Abbott Medical). A threshold of 0.2 mV (in AF) was used to define LVA as this has been shown to correlate with the conventional definition of 0.5 mV in sinus rhythm and with the presence of a scar on MRI.
,
Pulmonary vein isolation (PVI) was then performed either by de novo wide area circumferential ablation (n = 6), or for redo procedures (n = 10) at regions of vein reconnection with contact force guidance (TactiCath SE; Abbott Medical). Power settings were by operator preference either 30 W anteriorly/25 W posteriorly, guided by Lesion Index (LSI; Abbott Medical), or 45 W up to 15 s “high power, short duration”. Following PVI a further 30 s map (post‐PVI) of AF was acquired using AcQMap. AcQTrack software (Acutus Medical) was used to identify CDA (LIA, LRA, FA) targets and thresholds of 5, 7 and 1 for LRA, LIA, and FA, respectively, gave clinically usable maps with similar numbers of CDA in the majority of our patients. These were ablated at operator discretion. Two patients were ablated directly to sinus rhythm, while the remainder completed the procedure with external cardioversion. Clinical follow‐up was undertaken using a combination of patient symptoms, 12 lead EKG, and continuous EKG recordings.
Image registration
Comparing left atrial (LA) maps across multiple patients is challenging due to variation in LA size and geometry. In order to accurately compare maps from the two systems and across patients, in‐house methods were developed within Matlab (Version 2020a; www.mathworks.com) and Cloud Compare software (Version 2.6.1; www.cloudcompare.org) to merge maps. Fiducial markers were used to tag structures common to both geometries, typically the LA appendage and the carina between pulmonary veins, in order to generate a transformation matrix which is then used to align, resize, and rotate maps. Next, a “nearest neighbor” matching algorithm was used to apply bipolar voltage values from the Ensite Precision map onto the AcQMap geometry. This allows direct comparison of CDA and voltage for each vertex in the map.For the composite images, an average LA geometry was generated. Again, fiducial points were marked and used to transform each patient's geometry to the common LA geometry, before the nearest‐neighbor matching applied the thresholded CDA and voltage values to the common geometry. The number of occurrences of above‐threshold CDA, and the mean of the voltage at each vertex, were used to create LA heatmaps.
Image comparison and statistical methods
The detection of LVA and CDA in the LA is threshold dependent. A commonly used metric for medical image comparison, Sørenson Dice coefficient, is sensitive to changes in the thresholds used, so we compared maps using a novel area under the curve (AUC) metric. Our AUC metric calculates the AUC of a sensitivity/(1‐specificity) plot using a continually‐varying threshold for each of the two maps being compared. This is analogous to the area under a receiver‐operating characteristic (ROC) curve except that both the ‘test’ and ‘reference’ maps are from the same dataset and are both are subject to varying thresholds. This differs from the binary outcome of a gold‐standard reference test used when comparing diagnostic test accuracy—the typical application of ROC. Therefore, in this application, AUC values of <0.5 are possible for inversely matched maps (where CDAs have less intersection between maps than would be expected by chance), whereas a perfect match scores 1.0. This method has the substantial advantage that, by analyzing every possible CDA threshold, it removes the requirement for a threshold to be chosen.Due to constraints of clinical workflow, of 16 patients treated, 11 had the full set of data comprising bipolar voltage map, pre‐PVI CDA map, and post‐PVI CDA map. The primary analysis of temporal stability was performed on these 11 patients, but we also used all available datasets across all 16 patients for a secondary analysis (provided as a supplement). To assess single map temporal stability, a 30 s CDA acquisition was divided into three consecutive 10 s sections. Within each 10 s section, the locations of each CDA were annotated to create binary maps of the LA with FA/LRA/LIA present or absent. Each 10 s section (1, 2, 3) was compared against the other sections within the same 30 s window using AUC i.e. 1 vs. 2, 2 vs. 3, and 1 vs. 3. To compare longer term (intraprocedural) temporal stability, we compared the 30 s pre‐PVI recordings with 30 s recordings post‐PVI. Figure 2 gives an overview of all comparisons performed.
FIGURE 2
Summary of workflow undertaken to compare bipolar voltage and charge density, and to assess short‐ and long‐term temporal stability of charge density activation
Summary of workflow undertaken to compare bipolar voltage and charge density, and to assess short‐ and long‐term temporal stability of charge density activationBaseline demographic data are presented as mean ± SD or median (range) as appropriate. All pairwise comparisons were performed with Wilcoxon signed‐rank test (R, The R Project for Statistical Computing).
RESULTS
Patient characteristics are shown in Table 1.
TABLE 1
Patient characteristics. Continuous variables are described using mean ± SD unless otherwise stated
Age (years)
63 ± 11
AF history (years)
4.2 ± 3.0
Gender (M:F)
15:1
Body mass index (kg/m2)
29 ± 4
CHA2DS2‐VaSC score–median (range)
1 (0–4)
LV ejection fraction (%)
52 ± 5
LA dimension (mm)
46 ± 5
Previous AF ablation procedures–median (range)
Antiarrhythmic drugs at time of procedure
Betablockers
14/16
Digoxin
3/16
Amiodarone
1/16
Patients with previous AF ablation procedure
10/16, median 1 (0–3) procedures
Patient characteristics. Continuous variables are described using mean ± SD unless otherwise stated
Spatial distribution and co‐localization of CDA and relationship to voltage
The spatial distribution of LRA, LIA, and FA regions for all patients during the baseline 30 s AF recording is shown on a common geometry—Figure 3. There was some preferential location in anterior/septal wall, but CDA could be observed throughout the LA. The LIA and FA patterns were more frequently observed than LRA. At the clinically used thresholds, 55% of the atrial endocardial surface was involved in activation across one or more LRA, LIA, or FA. The Venn diagrams for complete cases and for all available data (Figure 4 and Figure S1 respectively) show the overlap for CDA types—LRA was rarely observed in isolation and mainly occurred in association with LIA or FA, while LIA and FA occurred more often in isolation. Across all patients studied, the median LA voltage was 0.39 mV (IQR 0.16–0.83). Comparing LA voltage in areas where CDA were present or absent, nominally significant differences were observed, with lower voltage in areas with LIA. However, there was a large range of data and no clinically meaningful differences were identified (Figure 5, Figure S2).
FIGURE 3
Composite images demonstrating spatial distribution and frequency (normalized to scale 0–1) of CDA, for all patients displayed on a common geometry; (A) AP and (B) PA views. CDA, charge density activation; FA, focal activity; LIA, local irregular activity; LRA, local rotational activity
FIGURE 4
Venn diagram demonstrating the involvement of left atrium (percentage of LA area) and degree of spatial overlap between charge density activity, complete datasets only. CDA, charge density activation pattern comprising LRA (local rotational activity); LIA, local irregular activity and FA, focal activity
FIGURE 5
Bipolar tissue voltage, in areas with and without CDA present, complete datasets only. Pairwise comparisons with Wilcoxon signed‐rank (****, p < .0001. ns, not significant). CDA, charge density activation pattern comprising LRA (local rotational activity); FA, focal activity; LIA, local irregular activity
Composite images demonstrating spatial distribution and frequency (normalized to scale 0–1) of CDA, for all patients displayed on a common geometry; (A) AP and (B) PA views. CDA, charge density activation; FA, focal activity; LIA, local irregular activity; LRA, local rotational activityVenn diagram demonstrating the involvement of left atrium (percentage of LA area) and degree of spatial overlap between charge density activity, complete datasets only. CDA, charge density activation pattern comprising LRA (local rotational activity); LIA, local irregular activity and FA, focal activityBipolar tissue voltage, in areas with and without CDA present, complete datasets only. Pairwise comparisons with Wilcoxon signed‐rank (****, p < .0001. ns, not significant). CDA, charge density activation pattern comprising LRA (local rotational activity); FA, focal activity; LIA, local irregular activity
Temporal stability of observed CDA
Within the 30 s pre‐PVI recordings of AF, when 10 s segments were compared in individual patients to examine short‐term CDA stability, we observed a high degree of CDA overlap, indicating stable patterns of CDA (Figure 6, Figure S3). At both timepoints, LIA was the most spatially stable form of CDA.
FIGURE 6
Short‐term temporal stability expressed as AUC (comparing 10 s sections within the same 30 s window), complete datasets only. Pairwise comparisons with Wilcoxon signed‐rank (****, p < .0001. ns, not significant). CDA, charge density activation pattern comprising LRA (local rotational activity); FA, focal activity; LIA, local irregular activity; PVI, pulmonary vein isolation; UAC, area under the curve metric
Short‐term temporal stability expressed as AUC (comparing 10 s sections within the same 30 s window), complete datasets only. Pairwise comparisons with Wilcoxon signed‐rank (****, p < .0001. ns, not significant). CDA, charge density activation pattern comprising LRA (local rotational activity); FA, focal activity; LIA, local irregular activity; PVI, pulmonary vein isolation; UAC, area under the curve metricComparing the pre‐ and post‐PVI maps (with a mean ± SD intervening time period of 100 ± 50 min) to assess longer term CDA stability, the observation of stable CDA patterns was again seen over this much longer time period (Figure 7, Figure S4).
FIGURE 7
Long‐term temporal stability expressed as AUC (comparing 30 s maps from the pre‐PVI and post‐PVI recordings), complete datasets only. Pairwise comparisons with Wilcoxon signed‐rank (ns = not significant, *p < .05). AUC, area under the curve metric; CDA, charge density activation pattern comprising LRA (local rotational activity); FA, focal activity; LIA, local irregular activity; PVI, pulmonary vein isolation
Long‐term temporal stability expressed as AUC (comparing 30 s maps from the pre‐PVI and post‐PVI recordings), complete datasets only. Pairwise comparisons with Wilcoxon signed‐rank (ns = not significant, *p < .05). AUC, area under the curve metric; CDA, charge density activation pattern comprising LRA (local rotational activity); FA, focal activity; LIA, local irregular activity; PVI, pulmonary vein isolation
DISCUSSION
In this study using a novel mapping system in persistent AF patients, the main findings were:Temporally stable, regions of activation during persistent AF the location of which varied between patients.Localized irregular activity was frequently observed and showed high temporal stability, while rotational activity was less frequent.CDA did not correlate well with low voltage regions mapped during AF.The observation of directional organization or “linking” during AF has been recognized previously, suggested to represent underlying anatomic structures or refractoriness from previous wavefronts.
,
Our data using high resolution global non‐contact mapping confirms that repetitive patterns of activity can be observed over timescales of <1 min, and greater than 1 h, which may be more consistent with a “driver” mechanism than “multiple wavelets”. This extends previous observations during epicardial perioperative maps acquired over the course of 10 min of AF.
Our long‐term stability assessment was performed by comparing pre‐PVI and post‐PVI data. We accept interim ablation may affect the AF substrate, although one might expect this to reduce temporal stability. Mapping with unipolar signals mitigates against some of the downsides of bipolar electrograms, including sensitivity to wavefront direction and loss of fine detail of complex activation patterns or “bipolar blindness”.With regard to specific CDA events, our data indicate that rotational activity, particularly occurring in isolation, was infrequent. This is consistent with previous reports using biatrial epicardial contact mapping studies
,
and also by mapping the epicardium non‐invasively using CardioInsight (Medtronic).
Studies that report more consistent findings of rotors, tend to depend on phase analysis methods.
,
The appearance of rotational activity can be a passive phenomenon based on phase analysis of electrograms at lines of conduction block.
We observed frequent and consistent endocardial FA which could represent either focal or micro re‐entrant drivers or epicardial to endocardial breakthrough. In a previous high density epicardial mapping study predominantly focal activations were observed with collision and merging of wavefronts.Atrial bipolar voltage is commonly used clinically as a surrogate for atrial substrate, despite potential limitations including wavefront direction and regional variation in LA wall thickness. Although voltage values were nominally statistically different in areas of CDA versus non‐CDA, this was likely due to the sheer number of points compared. More importantly, the significant overlap made it impossible to identify any clinically useful voltage threshold to identify CDA locations. This has also been recently reported by Chierchia et al.
—LVA identified during paced and sinus rhythm (but not during AF) did not overlap with CDA locations. Yet the consistent observation of temporally stable activity in patient‐specific locations, LIA in particular, strongly suggests this reflects an underlying fixed atrial substrate. Our observations regarding the frequent occurrence of LIA confirm those of others using this approach.
,
,
Using optical mapping ex vivo, fibrotic regions have been shown to harbor microscopic intramural re‐entrant circuits that can act as AF drivers.
However, current human in vivo electrophysiological and imaging methods are limited to either the endocardial or epicardial surface and lack the resolution to resolve this microscopic level of detail. Prior endocardial non‐contact mapping studies using the Ensite array failed to show stable dominant frequency sites, or stable focal or rotor sites.
,
However, this earlier generation system was of lower spatial resolution and does not utilize accurate patient‐specific ultrasound chamber geometry. Using the current system, LIA locations detected during AF co‐localize to areas of slow conduction during non‐AF paced rhythm, providing further evidence that these represent localized areas of abnormal substrate.Acute AF termination during ablation was a relatively infrequent occurrence in this study, but freedom from AF observed after ablation in this and other studies using this mapping system suggests that areas of CDA identified for ablation were involved in maintenance of AF.
,
The findings in this study of temporally stable CDA locations during AF that vary from patient to patient would not support an approach of either empiric linear ablation or voltage based ablation for persistent AF. The AcQMap system allows a bespoke approach and provides the ability to rapidly map, ablate and remap. The clinical effectiveness of non‐contact charge density guided mapping for treatment of AF is being evaluated in ongoing larger trials (e.g. RECOVER, NCT03368781 and DISCOVER, NCT0389333).
LIMITATIONS
The population studied had mostly longstanding persistent AF, and observations here may not apply to all forms of AF. Mapping in this study was confined to the endocardial LA, and we did not perform right atrial mapping.
CONCLUSIONS
This study of persistent AF has demonstrated temporally stable activation patterns over both short and relatively long periods of time, that appear unrelated to bipolar voltage. These may represent novel targets for AF ablation but this requires further investigation with larger clinical trials.
CONFLICT OF INTEREST
NFK has received an honorarium for participating in an Acutus Medical sponsored symposium. All other authors have no conflicts to declare.Fig S1Click here for additional data file.Fig S2Click here for additional data file.Fig S3Click here for additional data file.Fig S4Click here for additional data file.
Authors: Andrew W Teh; Peter M Kistler; Geoffrey Lee; Caroline Medi; Patrick M Heck; Steven J Spence; Paul B Sparks; Joseph B Morton; Jonathan M Kalman Journal: J Cardiovasc Electrophysiol Date: 2011-09-28
Authors: Sascha Rolf; Simon Kircher; Arash Arya; Charlotte Eitel; Philipp Sommer; Sergio Richter; Thomas Gaspar; Andreas Bollmann; David Altmann; Carlos Piedra; Gerhard Hindricks; Christopher Piorkowski Journal: Circ Arrhythm Electrophysiol Date: 2014-08-23
Authors: Rui Shi; Zhong Chen; Charlie Butcher; Junaid Ab Zaman; Vennela Boyalla; Yi Kan Wang; Omar Riad; Anitha Sathishkumar; Mark Norman; Shouvik Haldar; David G Jones; Wajid Hussain; Vias Markides; Tom Wong Journal: J Arrhythm Date: 2020-05-20
Authors: Geoffrey Lee; Saurabh Kumar; Andrew Teh; Andrew Madry; Steven Spence; Marco Larobina; John Goldblatt; Robin Brown; Victoria Atkinson; Simon Moten; Joseph B Morton; Prashanthan Sanders; Peter M Kistler; Jonathan M Kalman Journal: Eur Heart J Date: 2013-08-08 Impact factor: 29.983
Authors: Julian W E Jarman; Tom Wong; Pipin Kojodjojo; Hilmar Spohr; Justin E Davies; Michael Roughton; Darrel P Francis; Prapa Kanagaratnam; Vias Markides; D Wyn Davies; Nicholas S Peters Journal: Circ Arrhythm Electrophysiol Date: 2012-06-20
Authors: Tomos E Walters; Geoffrey Lee; Gwilym Morris; Steven Spence; Marco Larobina; Victoria Atkinson; Phillip Antippa; John Goldblatt; Alistair Royse; Michael O'Keefe; Prashanthan Sanders; Joseph B Morton; Peter M Kistler; Jonathan M Kalman Journal: JACC Clin Electrophysiol Date: 2015-04-20